Kindly MD (NAKAW) Financials

$0.86 +0.06 (+8.00%)
As of 11:30 AM Eastern
Annual Income Statements for Kindly MD

Annual Income Statements for Kindly MD

This table shows Kindly MD's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-1.62 -3.62 -52
Consolidated Net Income / (Loss)
-1.62 -3.62 -52
Net Income / (Loss) Continuing Operations
-1.62 -3.62 -52
Total Pre-Tax Income
-1.62 -3.62 -52
Total Operating Income
-1.62 -3.35 -197
Total Gross Profit
3.77 2.72 1.82
Total Revenue
3.77 2.72 1.82
Operating Revenue
3.77 2.72 1.82
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
5.39 6.07 199
Selling, General & Admin Expense
1.36 1.91 12
Depreciation Expense
0.11 0.14 0.08
Other Operating Expenses / (Income)
3.92 4.02 187
Total Other Income / (Expense), net
0.00 -0.27 145
Interest Expense
0.06 0.43 22
Other Income / (Expense), net
0.06 0.16 167
Income Tax Expense
0.00 0.00 0.00
Basic Earnings per Share
($0.36) ($0.67) ($0.26)
Weighted Average Basic Shares Outstanding
4.50M 5.39M 200.20M
Diluted Earnings per Share
($0.36) ($0.67) ($0.26)
Weighted Average Diluted Shares Outstanding
4.50M 5.39M 200.20M
Weighted Average Basic & Diluted Shares Outstanding
- 6.03M 690.02M

Quarterly Income Statements for Kindly MD

This table shows Kindly MD's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133 86
Consolidated Net Income / (Loss)
-0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133 86
Net Income / (Loss) Continuing Operations
-0.28 -1.32 -1.01 -1.00 -1.04 0.00 -82 37 -239 -131 86
Total Pre-Tax Income
-0.28 -1.32 -1.01 -1.00 -1.04 0.00 -82 37 -239 -153 89
Total Operating Income
-0.24 -1.04 -1.05 -1.02 -1.04 0.00 -30 -183 -126 -149 92
Total Gross Profit
0.83 0.64 0.65 0.60 0.58 0.00 0.00 0.44 2.68 36 -1.93
Total Revenue
0.83 0.64 0.65 0.60 0.58 0.00 0.00 0.44 2.68 36 -1.93
Operating Revenue
0.83 0.64 0.65 0.60 0.58 0.00 0.00 0.44 2.68 36 -1.93
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
1.07 1.68 1.70 1.63 1.62 0.00 30 184 129 185 -94
Selling, General & Admin Expense
0.29 0.44 0.53 0.65 0.59 0.00 3.01 5.07 9.78 4.70 4.14
Depreciation Expense
0.02 0.03 0.03 0.06 0.02 0.00 0.00 0.04 1.12 2.43 2.30
Other Operating Expenses / (Income)
0.72 0.86 1.15 1.30 1.01 0.00 27 179 118 73 -100
Impairment Charge
- - - - - 0.00 0.00 - - 105 0.00
Total Other Income / (Expense), net
-0.05 -0.28 0.04 0.02 0.00 0.00 -52 221 -113 -3.54 -3.34
Interest Expense
0.06 0.36 0.01 0.01 0.01 0.00 14 7.32 4.22 4.02 3.39
Other Income / (Expense), net
0.01 0.07 0.05 0.03 0.01 0.00 -38 228 -108 0.47 0.05
Income Tax Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 -21 2.77
Net Income / (Loss) Discontinued Operations
- - - - - -2.41 -3.81 - - -1.80 -0.27
Basic Earnings per Share
($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($14.20) ($16.95) $0.68 ($0.38) ($6.65) $4.25
Weighted Average Basic Shares Outstanding
4.62M 5.01M 5.94M 5.39M 6.03M 170.00 5.08M 200.20M 636.47M 20M 20.14M
Diluted Earnings per Share
($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($14.20) ($16.95) $0.68 ($0.38) ($6.65) $4.07
Weighted Average Diluted Shares Outstanding
4.62M 5.01M 5.94M 5.39M 6.03M 170.00 5.08M 200.20M 636.47M 20M 21.03M
Weighted Average Basic & Diluted Shares Outstanding
5.94M 5.95M 5.98M 6.03M 6.02M 7.61M 439.85M 690.02M 696.09M 17.89M 18.35M

Annual Cash Flow Statements for Kindly MD

This table details how cash moves in and out of Kindly MD's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.34 1.75 20
Net Cash From Operating Activities
-0.45 -3.07 -24
Net Cash From Continuing Operating Activities
-0.45 -3.07 -24
Net Income / (Loss) Continuing Operations
-1.62 -3.62 -52
Consolidated Net Income / (Loss)
-1.62 -3.62 -52
Depreciation Expense
0.11 0.14 0.08
Amortization Expense
0.12 0.46 2.98
Non-Cash Adjustments To Reconcile Net Income
0.75 0.24 30
Changes in Operating Assets and Liabilities, net
0.19 -0.29 -4.06
Net Cash From Investing Activities
-0.01 -0.40 -680
Net Cash From Continuing Investing Activities
-0.01 -0.40 -680
Purchase of Property, Plant & Equipment
-0.01 -0.40 -0.23
Acquisitions
- - 0.19
Purchase of Investments
- 0.00 -30
Sale and/or Maturity of Investments
- 0.00 5.05
Other Investing Activities, net
- 0.00 -655
Net Cash From Financing Activities
0.80 5.22 724
Net Cash From Continuing Financing Activities
0.80 5.22 724
Repayment of Debt
-0.06 -0.66 -204
Repurchase of Common Equity
0.00 -0.02 -0.32
Issuance of Debt
0.86 0.05 192
Issuance of Common Equity
0.00 5.86 524
Other Financing Activities, net
0.00 -0.00 212
Cash Interest Paid
0.03 0.02 0.00
Cash Income Taxes Paid
0.00 0.00 0.00

Quarterly Cash Flow Statements for Kindly MD

This table details how cash moves in and out of Kindly MD's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-0.24 4.45 -1.10 -1.37 -1.13 4.88 18 -1.60 13 -15 0.35
Net Cash From Operating Activities
-0.21 -0.91 -1.05 -0.90 -0.87 -1.91 -13 -7.57 -23 -3.25 -10
Net Cash From Continuing Operating Activities
-0.21 -0.91 -1.05 -0.90 -0.87 -1.91 -13 -7.57 -23 -1.11 -8.56
Net Income / (Loss) Continuing Operations
-0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133 86
Consolidated Net Income / (Loss)
-0.28 -1.32 -1.01 -1.00 -1.04 -2.41 -86 37 -239 -133 86
Depreciation Expense
0.02 0.03 0.03 0.06 0.02 0.01 0.01 0.04 1.12 2.41 2.30
Non-Cash Adjustments To Reconcile Net Income
-0.02 0.01 0.12 0.13 0.08 0.72 76 -47 221 141 -96
Changes in Operating Assets and Liabilities, net
-0.01 0.03 -0.21 -0.11 0.08 -0.27 -4.19 0.30 -6.24 -11 -0.05
Net Cash From Discontinued Operating Activities
- - - - - - - - - - -1.73
Net Cash From Investing Activities
-0.01 - -0.00 -0.39 -0.17 -2.35 -684 6.28 37 -2.26 11
Net Cash From Continuing Investing Activities
-0.01 - -0.00 -0.39 -0.17 -2.35 -684 6.28 37 -2.26 11
Purchase of Property, Plant & Equipment
-0.01 - -0.00 -0.39 -0.17 -0.06 -0.00 -0.00 0.00 -0.60 -0.23
Other Investing Activities, net
- - - - 0.00 - -639 -14 17 -1.60 11
Cash Interest Paid
0.00 0.02 0.00 0.00 0.00 0.00 -0.00 - 0.00 1.45 0.95

Annual Balance Sheets for Kindly MD

This table presents Kindly MD's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
1.10 3.68 731
Total Current Assets
0.62 2.51 224
Cash & Equivalents
0.53 2.27 21
Prepaid Expenses
0.00 0.23 2.14
Other Current Assets
- 0.00 199
Other Current Nonoperating Assets
- - 1.55
Plant, Property, & Equipment, net
0.24 0.00 0.00
Total Noncurrent Assets
0.25 1.17 507
Long-Term Investments
- 0.00 36
Goodwill
- - 0.00
Intangible Assets
0.00 0.00 3.01
Other Noncurrent Operating Assets
0.25 1.17 468
Other Noncurrent Nonoperating Assets
- - 0.54
Total Liabilities & Shareholders' Equity
1.10 3.68 731
Total Liabilities
1.21 1.11 216
Total Current Liabilities
0.81 0.61 216
Short-Term Debt
0.15 0.14 210
Accounts Payable
0.33 0.32 5.04
Other Current Liabilities
0.33 0.14 0.44
Other Current Nonoperating Liabilities
- - 0.95
Total Noncurrent Liabilities
0.39 0.50 0.37
Long-Term Debt
0.23 - 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
- - 0.00
Other Noncurrent Operating Liabilities
0.16 0.50 0.00
Other Noncurrent Nonoperating Liabilities
- - 0.37
Total Equity & Noncontrolling Interests
-0.11 2.57 514
Total Preferred & Common Equity
-0.11 2.57 514
Preferred Stock
0.00 0.00 0.00
Total Common Equity
-0.11 2.57 514
Common Stock
4.05 10 575
Retained Earnings
-4.16 -7.78 -60
Treasury Stock
0.00 -0.02 -0.75
Accumulated Other Comprehensive Income / (Loss)
- - 0.00

Quarterly Balance Sheets for Kindly MD

This table presents Kindly MD's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
0.80 5.46 4.32 2.56 9.89 692 621 423 517
Total Current Assets
0.36 5.05 3.94 1.29 6.37 27 63 27 29
Cash & Equivalents
0.29 4.74 3.64 1.14 6.02 24 35 19 19
Prepaid Expenses
0.01 0.31 0.25 0.14 0.34 2.87 14 4.49 3.97
Other Current Assets
- - - - - - 14 3.89 5.64
Other Current Nonoperating Assets
- - - - - - - 0.00 0.00
Plant, Property, & Equipment, net
0.22 0.21 0.18 0.11 0.08 0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.22 0.20 0.20 1.16 3.43 665 557 395 488
Long-Term Investments
- - - - - 46 17 18 18
Goodwill
- - - - - - 94 16 19
Intangible Assets
- - - 0.56 0.62 3.01 101 97 91
Other Noncurrent Operating Assets
0.22 0.20 0.20 0.60 0.56 616 0.19 264 360
Other Noncurrent Nonoperating Assets
- - - - 2.25 - 346 0.00 0.00
Total Liabilities & Shareholders' Equity
0.80 5.46 4.32 2.56 9.89 692 621 423 517
Total Liabilities
1.18 1.08 0.84 1.03 0.92 215 254 186 193
Total Current Liabilities
0.86 0.94 0.73 0.56 0.49 214 252 179 127
Short-Term Debt
0.20 0.23 0.19 0.06 0.00 203 210 165 105
Accounts Payable
0.30 0.63 0.43 0.37 0.36 5.85 13 11 7.66
Current Deferred Revenue
- - - - - - 23 3.45 6.06
Other Current Liabilities
0.36 0.08 0.10 0.13 0.13 5.60 5.75 0.35 8.80
Other Current Nonoperating Liabilities
- - - - - - - 0.00 0.00
Total Noncurrent Liabilities
0.32 0.13 0.11 0.47 0.43 0.40 1.99 6.63 65
Long-Term Debt
0.18 0.00 0.00 - - - - - 60
Noncurrent Deferred Revenue
- - - - - - 1.62 3.78 0.87
Noncurrent Deferred & Payable Income Tax Liabilities
- - - - - - - 2.50 4.34
Other Noncurrent Operating Liabilities
0.14 0.13 0.11 0.47 0.43 0.40 0.37 0.35 0.32
Other Noncurrent Nonoperating Liabilities
- - - - - - - 0.00 0.00
Total Equity & Noncontrolling Interests
-0.38 4.38 3.48 1.53 8.97 478 367 236 324
Total Preferred & Common Equity
-0.38 4.38 3.48 1.53 8.97 478 367 236 324
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-0.38 4.38 3.48 1.53 8.97 478 367 236 324
Common Stock
4.06 10 10 10 20 575 666 668 671
Retained Earnings
-4.44 -5.76 -6.77 -8.81 -11 -97 -299 -432 -346
Treasury Stock
- - - -0.03 0.00 0.00 0.00 0.00 0.00
Accumulated Other Comprehensive Income / (Loss)
- - - - - - -0.13 -0.22 -0.07

Annual Metrics And Ratios for Kindly MD

This table displays calculated financial ratios and metrics derived from Kindly MD's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 5,977,476.00 439,850,889.00
DEI Adjusted Shares Outstanding
0.00 5,977,476.00 439,850,889.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -0.61 -0.12
Growth Metrics
- - -
Revenue Growth
0.00% -27.83% -33.04%
EBITDA Growth
0.00% -93.60% -956.88%
EBIT Growth
0.00% -103.98% -855.82%
NOPAT Growth
0.00% -106.56% -5,790.43%
Net Income Growth
0.00% -123.66% -1,343.73%
EPS Growth
0.00% -86.11% 61.19%
Operating Cash Flow Growth
0.00% -583.86% -664.88%
Free Cash Flow Firm Growth
0.00% 0.00% -26,376.71%
Invested Capital Growth
0.00% 269.17% 153,262.15%
Revenue Q/Q Growth
0.00% -5.41% -8.03%
EBITDA Q/Q Growth
0.00% -38.40% 63.56%
EBIT Q/Q Growth
0.00% -28.35% 59.95%
NOPAT Q/Q Growth
0.00% -27.43% -1,226.52%
Net Income Q/Q Growth
0.00% -23.01% 42.28%
EPS Q/Q Growth
0.00% -17.54% 76.79%
Operating Cash Flow Q/Q Growth
0.00% -29.10% -39.57%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -29.36%
Invested Capital Q/Q Growth
0.00% 1,046.96% 9.03%
Profitability Metrics
- - -
Gross Margin
100.00% 100.00% 100.00%
EBITDA Margin
-35.51% -95.24% -1,503.20%
Operating Margin
-42.99% -123.05% -10,824.01%
EBIT Margin
-41.44% -117.11% -1,671.63%
Profit (Net Income) Margin
-42.92% -133.01% -2,867.65%
Tax Burden Percent
100.00% 100.00% 100.00%
Interest Burden Percent
103.58% 113.57% 171.55%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -2,640.61% -41.44%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -2,528.90% 73.57%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2,346.48% 21.23%
Return on Equity (ROE)
1,491.96% -294.13% -20.21%
Cash Return on Invested Capital (CROIC)
0.00% -698.96% -241.18%
Operating Return on Assets (OROA)
-142.07% -133.35% -8.29%
Return on Assets (ROA)
-147.15% -151.45% -14.23%
Return on Common Equity (ROCE)
1,491.96% -294.13% -20.21%
Return on Equity Simple (ROE_SIMPLE)
1,491.96% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-1.13 -2.34 -138
NOPAT Margin
-30.09% -86.14% -7,576.80%
Net Nonoperating Expense Percent (NNEP)
-326.31% -111.71% -115.01%
Return On Investment Capital (ROIC_SIMPLE)
-421.66% -86.53% -19.07%
Cost of Revenue to Revenue
0.00% 0.00% 0.00%
SG&A Expenses to Revenue
35.98% 70.12% 645.82%
R&D to Revenue
0.07% 0.00% 0.00%
Operating Expenses to Revenue
142.99% 223.05% 10,924.01%
Earnings before Interest and Taxes (EBIT)
-1.56 -3.19 -30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1.34 -2.59 -27
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 2.89 0.30
Price to Tangible Book Value (P/TBV)
0.00 2.89 0.30
Price to Revenue (P/Rev)
1.86 2.73 84.79
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 12.16 0.46
Enterprise Value to Revenue (EV/Rev)
1.82 1.94 167.85
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
-3.48 0.05 0.41
Long-Term Debt to Equity
-2.11 0.00 0.00
Financial Leverage
1.37 -0.93 0.29
Leverage Ratio
-10.14 1.94 1.42
Compound Leverage Factor
-10.50 2.21 2.44
Debt to Total Capital
140.31% 5.14% 28.95%
Short-Term Debt to Total Capital
55.22% 5.14% 28.95%
Long-Term Debt to Total Capital
85.09% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
-40.31% 94.86% 71.05%
Debt to EBITDA
-0.28 -0.05 -7.65
Net Debt to EBITDA
0.11 0.82 -5.53
Long-Term Debt to EBITDA
-0.17 0.00 0.00
Debt to NOPAT
-0.33 -0.06 -1.52
Net Debt to NOPAT
0.13 0.91 -1.10
Long-Term Debt to NOPAT
-0.20 0.00 0.00
Altman Z-Score
-3.29 -0.45 0.19
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
0.76 4.13 1.04
Quick Ratio
0.68 3.75 0.10
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -3.03 -803
Operating Cash Flow to CapEx
-3,117.12% -765.35% -10,031.23%
Free Cash Flow to Firm to Interest Expense
0.00 -7.02 -36.87
Operating Cash Flow to Interest Expense
-8.05 -7.11 -1.08
Operating Cash Flow Less CapEx to Interest Expense
-8.31 -8.04 -1.09
Efficiency Ratios
- - -
Asset Turnover
3.43 1.14 0.01
Accounts Receivable Turnover
134.59 0.00 0.00
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
16.02 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
2.71 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
2.71 0.00 0.00
Capital & Investment Metrics
- - -
Invested Capital
-0.26 0.43 666
Invested Capital Turnover
-14.69 30.66 0.01
Increase / (Decrease) in Invested Capital
0.00 0.69 665
Enterprise Value (EV)
6.85 5.28 306
Market Capitalization
7.00 7.41 154
Book Value per Share
($0.02) $0.43 $1.17
Tangible Book Value per Share
($0.02) $0.43 $1.16
Total Capital
0.27 2.71 724
Total Debt
0.38 0.14 210
Total Long-Term Debt
0.23 0.00 0.00
Net Debt
-0.15 -2.13 151
Capital Expenditures (CapEx)
0.01 0.40 0.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.57 -0.23 195
Debt-free Net Working Capital (DFNWC)
-0.05 2.04 217
Net Working Capital (NWC)
-0.20 1.90 7.83
Net Nonoperating Expense (NNE)
0.48 1.27 -86
Net Nonoperating Obligations (NNO)
-0.15 -2.13 151
Total Depreciation and Amortization (D&A)
0.22 0.59 3.07
Debt-free, Cash-free Net Working Capital to Revenue
-15.24% -8.63% 10,695.95%
Debt-free Net Working Capital to Revenue
-1.30% 74.96% 11,935.88%
Net Working Capital to Revenue
-5.24% 69.84% 430.02%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 ($0.67) ($0.26)
Adjusted Weighted Average Basic Shares Outstanding
0.00 5.39M 200.20M
Adjusted Diluted Earnings per Share
$0.00 ($0.67) ($0.26)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 5.39M 200.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 6.03M 690.02M
Normalized Net Operating Profit after Tax (NOPAT)
-1.13 -2.34 -138
Normalized NOPAT Margin
-30.09% -86.14% -7,576.80%
Pre Tax Income Margin
-42.92% -133.01% -2,867.65%
Debt Service Ratios
- - -
EBIT to Interest Expense
-27.96 -7.37 -1.40
NOPAT to Interest Expense
-20.31 -5.42 -6.34
EBIT Less CapEx to Interest Expense
-28.22 -8.30 -1.41
NOPAT Less CapEx to Interest Expense
-20.57 -6.35 -6.35
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -0.61% -0.61%

Quarterly Metrics And Ratios for Kindly MD

This table displays calculated financial ratios and metrics derived from Kindly MD's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 5,939,516.00 5,947,169.00 5,977,476.00 6,029,648.00 6,022,148.00 7,606,339.00 439,850,889.00 690,018,254.00 696,085,586.00 17,894,943.00
DEI Adjusted Shares Outstanding
0.00 5,939,516.00 5,947,169.00 5,977,476.00 6,029,648.00 6,022,148.00 7,606,339.00 439,850,889.00 690,018,254.00 17,402,140.00 17,894,943.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -0.22 -0.17 -0.17 -0.17 -0.40 -11.31 0.08 -0.35 -7.64 4.78
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-28.55% -34.76% -25.47% -20.48% -30.04% -36.07% -40.08% -26.32% 361.72% 0.00% 0.00%
EBITDA Growth
-3.49% -12.87% -95.08% -362.57% -694.86% -292.32% -7,399.52% 5,207.89% -22,921.79% -812,083.33% 239.10%
EBIT Growth
-24.37% -63.60% -99.86% -242.76% -358.49% -150.45% -7,026.15% 4,587.26% -22,628.29% 0.00% 235.70%
NOPAT Growth
-15.56% -72.49% -105.20% -238.48% -339.43% -130.57% -891.17% -25,506.24% -12,008.45% 0.00% 527.52%
Net Income Growth
-56.00% -121.27% -96.87% -208.23% -267.66% -82.91% -8,383.56% 3,820.21% -22,903.47% -5,409.40% 199.43%
EPS Growth
-50.00% -100.00% -54.55% -125.00% -183.33% -34.62% -147.06% 477.78% -123.53% 53.17% 124.01%
Operating Cash Flow Growth
-227.73% -106.65% -3,160.44% -332.01% -305.27% -109.21% -1,159.60% -739.41% -2,591.91% -70.23% 21.91%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% -1,229.92% -319.84% -79,837.50% -60,227.34% -17,894.97% -56,777.33% 139.28%
Invested Capital Growth
0.00% 0.00% 0.00% 269.17% 253.59% 627.21% 1,613,278.46% 153,262.15% 39,116.07% 52,583.15% -26.03%
Revenue Q/Q Growth
9.16% -22.92% 1.38% -6.79% -3.96% -29.52% -4.97% 14.61% 501.90% 1,239.40% -105.38%
EBITDA Q/Q Growth
35.65% -370.51% -57.54% 3.02% -10.57% -148.21% -2,911.50% 166.05% -598.36% 37.37% 164.49%
EBIT Q/Q Growth
22.34% -327.53% -4.38% 1.10% -3.88% -133.61% -2,870.03% 162.28% -626.18% 36.64% 161.89%
NOPAT Q/Q Growth
21.51% -337.40% -1.22% 2.59% -1.89% -129.57% -335.11% -2,416.53% 51.82% -18.16% 185.33%
Net Income Q/Q Growth
13.11% -367.42% 23.15% 1.25% -3.64% -132.54% -3,464.35% 143.31% -740.86% 44.30% 164.32%
EPS Q/Q Growth
25.00% -333.33% 34.62% -5.88% 5.56% -105.88% -20.00% 261.90% -155.88% -1,650.00% 161.20%
Operating Cash Flow Q/Q Growth
-2.28% -328.01% -14.43% 13.76% 4.05% -120.93% -588.97% 42.53% -207.70% 86.03% -216.14%
Free Cash Flow Firm Q/Q Growth
0.00% -553.12% -29.91% -82.00% -5.47% -68.38% -24,635.32% -37.35% 68.54% -75.41% 152.96%
Invested Capital Q/Q Growth
-15.88% 55.85% 128.83% 1,046.96% 5.20% 51.55% 88,127.21% 9.03% -73.10% 103.59% 23.87%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00%
EBITDA Margin
-15.39% -93.92% -145.96% -151.86% -174.83% -576.42% -18,267.49% 10,528.00% -8,716.99% -407.57% 0.00%
Operating Margin
-28.60% -162.30% -162.04% -169.34% -179.66% -585.39% -2,680.39% -41,198.16% -4,711.35% -415.62% 0.00%
EBIT Margin
-27.15% -150.58% -155.05% -164.50% -177.93% -589.95% -18,438.86% 10,019.11% -8,758.63% -414.30% 0.00%
Profit (Net Income) Margin
-34.06% -206.50% -156.54% -165.85% -178.97% -590.85% -22,162.24% 8,374.17% -8,916.21% -370.79% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 87.14% 96.57%
Interest Burden Percent
125.43% 137.13% 100.96% 100.82% 100.58% 100.15% 120.19% 83.58% 101.80% 102.70% 96.32%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.13%
Return on Invested Capital (ROIC)
0.00% 0.00% -17,240.48% -3,634.01% -3,901.38% -3,274.28% -12.17% -225.34% -144.02% -63.39% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -17,224.27% -3,608.98% -3,838.83% -3,262.70% -133.86% 70.43% 15.10% -111.20% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 17,037.22% 3,348.65% 3,305.21% 3,125.66% -36.02% 20.32% -7.75% -54.30% 0.00%
Return on Equity (ROE)
448.63% -55.75% -203.26% -285.36% -596.17% -148.62% -48.19% -205.02% -151.77% -117.70% 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -698.96% -801.66% -675.99% -203.38% -241.18% -450.34% -379.93% -16.17%
Operating Return on Assets (OROA)
-116.76% -85.46% -103.10% -187.32% -261.46% -172.21% -104.81% 49.70% -110.14% -76.25% 0.00%
Return on Assets (ROA)
-146.45% -117.19% -104.09% -188.84% -262.98% -172.47% -125.98% 41.54% -112.13% -68.24% 0.00%
Return on Common Equity (ROCE)
448.63% -55.75% -203.26% -285.36% -596.17% -148.62% -48.19% -205.02% -151.77% -117.70% 0.00%
Return on Equity Simple (ROE_SIMPLE)
448.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.17 -0.73 -0.73 -0.72 -0.73 -1.67 -7.28 -183 -88 -104 89
NOPAT Margin
-20.02% -113.61% -113.43% -118.54% -125.76% -409.78% -1,876.27% -41,198.16% -3,297.95% -290.93% 0.00%
Net Nonoperating Expense Percent (NNEP)
270.97% -26.31% -16.21% -25.03% -62.56% -11.57% 121.69% -295.77% -159.12% 47.81% 2.69%
Return On Investment Capital (ROIC_SIMPLE)
1,681.41% -15.75% -19.97% -26.44% -45.67% -18.67% -1.07% -25.32% -15.31% -26.02% 18.20%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
35.00% 69.47% 81.15% 107.17% 102.24% 274.52% 1,283.52% 1,138.55% 365.35% 13.09% 0.00%
R&D to Revenue
4.27% 53.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
128.60% 262.30% 262.04% 269.34% 279.66% 685.39% 2,780.39% 41,298.16% 4,811.35% 515.62% 0.00%
Earnings before Interest and Taxes (EBIT)
-0.23 -0.96 -1.00 -0.99 -1.03 -2.41 -72 45 -235 -149 92
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.13 -0.60 -0.95 -0.92 -1.01 -2.35 -71 47 -233 -146 94
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 3.73 1.79 2.89 6.35 9.30 0.02 0.30 0.42 0.29 0.52
Price to Tangible Book Value (P/TBV)
0.00 3.73 1.79 2.89 10.04 9.99 0.02 0.30 0.88 0.56 0.79
Price to Revenue (P/Rev)
2.04 5.27 2.17 2.73 3.93 37.22 4.11 84.79 38.89 1.73 4.47
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 73.96 12.16 18.91 111.80 0.23 0.46 1.73 0.54 0.66
Enterprise Value to Revenue (EV/Rev)
2.06 3.82 0.97 1.94 3.49 34.53 71.21 167.85 79.09 4.95 7.83
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-0.97 0.05 0.06 0.05 0.04 0.00 0.43 0.41 0.57 0.70 0.51
Long-Term Debt to Equity
-0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.18
Financial Leverage
-0.22 -1.03 -0.99 -0.93 -0.86 -0.96 0.27 0.29 -0.51 0.49 0.32
Leverage Ratio
-2.09 1.25 1.24 1.94 2.93 1.15 1.45 1.42 1.69 1.76 1.51
Compound Leverage Factor
-2.62 1.71 1.25 1.96 2.95 1.15 1.74 1.19 1.72 1.81 1.45
Debt to Total Capital
-3,780.90% 4.95% 5.34% 5.14% 4.26% 0.00% 29.83% 28.95% 36.36% 41.06% 33.71%
Short-Term Debt to Total Capital
-1,985.05% 4.95% 5.12% 5.14% 3.82% 0.00% 29.83% 28.95% 36.36% 41.06% 21.45%
Long-Term Debt to Total Capital
-1,795.85% 0.00% 0.22% 0.00% 0.44% 0.00% 0.00% 0.00% 0.00% 0.00% 12.26%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
3,880.90% 95.05% 94.66% 94.86% 95.74% 100.00% 70.17% 71.05% 63.64% 58.94% 66.29%
Debt to EBITDA
-0.28 -0.16 -0.11 -0.05 -0.02 0.00 -2.70 -7.65 -0.80 -0.40 -0.67
Net Debt to EBITDA
-0.06 3.20 1.84 0.82 0.28 0.00 -1.77 -5.53 -0.60 -0.31 -0.52
Long-Term Debt to EBITDA
-0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.24
Debt to NOPAT
-0.32 -0.16 -0.11 -0.06 -0.02 0.00 -19.52 -1.52 -0.93 -0.50 -0.67
Net Debt to NOPAT
-0.07 3.09 1.87 0.91 0.37 0.00 -12.77 -1.10 -0.70 -0.39 -0.52
Long-Term Debt to NOPAT
-0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.25
Altman Z-Score
-1.61 8.52 3.06 1.52 0.80 52.72 -0.84 0.53 -1.92 -2.71 0.02
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.41 5.36 5.43 4.13 2.30 12.99 0.13 1.04 0.25 0.15 0.23
Quick Ratio
0.34 5.03 5.08 3.75 2.05 12.30 0.11 0.10 0.14 0.11 0.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.13 -0.59 -0.77 -1.41 -1.48 -2.50 -618 -848 -267 -468 248
Operating Cash Flow to CapEx
-1,908.77% 0.00% -49,567.80% -232.15% -500.00% -3,290.95% -460,568.94% -756,753,100.00% 0.00% -542.17% -4,570.67%
Free Cash Flow to Firm to Interest Expense
2.29 -1.66 -80.00 -173.62 -247.20 -680.80 -42.73 -115.92 -63.25 -116.58 73.21
Operating Cash Flow to Interest Expense
-3.73 -2.56 -108.23 -111.30 -144.17 -521.05 -0.91 -1.03 -5.52 -0.81 -3.04
Operating Cash Flow Less CapEx to Interest Expense
-3.92 -2.56 -108.45 -159.24 -173.00 -536.89 -0.91 -1.03 -5.52 -0.96 -3.10
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
4.30 0.57 0.67 1.14 1.47 0.29 0.01 0.01 0.01 0.18 0.06
Accounts Receivable Turnover
455.03 597.61 63.44 0.00 233.45 354.03 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
15.51 14.97 15.68 0.00 15.12 15.40 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.80 0.61 5.75 0.00 1.56 1.03 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.80 0.61 5.75 0.00 1.56 1.03 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-0.30 -0.13 0.04 0.43 0.46 0.69 610 666 179 365 452
Invested Capital Turnover
-23.13 -47.19 151.99 30.66 31.02 7.99 0.01 0.01 0.04 0.22 0.07
Increase / (Decrease) in Invested Capital
-0.30 -0.13 0.04 0.69 0.75 0.82 610 665 179 364 -159
Enterprise Value (EV)
7.09 12 2.80 5.28 8.64 77 141 306 310 197 297
Market Capitalization
7.00 16 6.24 7.41 9.71 83 8.14 154 152 69 169
Book Value per Share
($0.08) $0.74 $0.59 $0.43 $0.25 $1.49 $62.78 $1.17 $0.53 $0.34 $18.12
Tangible Book Value per Share
($0.08) $0.74 $0.59 $0.43 $0.16 $1.39 $62.39 $1.16 $0.25 $0.18 $11.96
Total Capital
-0.01 4.61 3.68 2.71 1.60 8.97 681 724 577 401 489
Total Debt
0.37 0.23 0.20 0.14 0.07 0.00 203 210 210 165 165
Total Long-Term Debt
0.18 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 60
Net Debt
0.09 -4.51 -3.45 -2.13 -1.07 -6.02 133 151 158 128 127
Capital Expenditures (CapEx)
0.01 0.00 0.00 0.39 0.17 0.06 0.00 0.00 0.00 0.60 0.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.60 -0.40 -0.24 -0.23 -0.35 -0.14 -8.58 195 -14 -6.39 -13
Debt-free Net Working Capital (DFNWC)
-0.31 4.34 3.40 2.04 0.79 5.88 16 217 21 13 6.52
Net Working Capital (NWC)
-0.51 4.11 3.22 1.90 0.73 5.88 -187 7.83 -188 -152 -98
Net Nonoperating Expense (NNE)
0.12 0.59 0.28 0.29 0.31 0.74 79 -221 150 29 3.50
Net Nonoperating Obligations (NNO)
0.09 -4.51 -3.45 -2.13 -1.07 -8.27 133 151 -188 128 127
Total Depreciation and Amortization (D&A)
0.10 0.36 0.06 0.08 0.02 0.06 0.67 2.26 1.12 2.41 2.30
Debt-free, Cash-free Net Working Capital to Revenue
-17.36% -12.92% -8.31% -8.63% -14.06% -6.37% -433.04% 10,695.95% -353.12% -16.06% -34.08%
Debt-free Net Working Capital to Revenue
-9.00% 140.14% 118.39% 74.96% 32.10% 262.59% 788.26% 11,935.88% 547.54% 31.87% 17.22%
Net Working Capital to Revenue
-14.70% 132.77% 111.83% 69.84% 29.63% 262.59% -9,463.71% 430.02% -4,803.90% -382.08% -259.90%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($0.35) ($0.42) $0.68 ($0.38) ($6.65) $4.25
Adjusted Weighted Average Basic Shares Outstanding
4.62M 5.01M 5.94M 5.39M 6.02M 6.82M 203.09M 200.20M 636.47M 20M 20.14M
Adjusted Diluted Earnings per Share
($0.06) ($0.26) ($0.17) ($0.18) ($0.17) ($0.35) ($0.42) $0.68 ($0.38) ($6.65) $4.07
Adjusted Weighted Average Diluted Shares Outstanding
4.62M 5.01M 5.94M 5.39M 6.02M 6.82M 203.09M 200.20M 636.47M 20M 21.03M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
5.94M 5.95M 5.98M 6.03M 6.02M 7.61M 439.85M 690.02M 696.09M 17.89M 18.35M
Normalized Net Operating Profit after Tax (NOPAT)
-0.17 -0.73 -0.73 -0.72 -0.73 -1.67 -7.28 -128 -88 -31 89
Normalized NOPAT Margin
-20.02% -113.61% -113.43% -118.54% -125.76% -409.78% -1,876.27% -28,838.71% -3,297.95% -85.68% 0.00%
Pre Tax Income Margin
-34.06% -206.50% -156.54% -165.85% -178.97% -590.85% -22,162.24% 8,374.17% -8,916.21% -425.50% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-3.93 -2.69 -104.00 -122.64 -172.00 -657.07 -4.95 6.09 -55.58 -37.00 27.15
NOPAT to Interest Expense
-2.90 -2.03 -76.08 -88.38 -121.57 -456.39 -0.50 -25.05 -20.93 -25.98 26.29
EBIT Less CapEx to Interest Expense
-4.13 -2.69 -104.21 -170.59 -200.83 -672.90 -4.95 6.09 -55.58 -37.15 27.09
NOPAT Less CapEx to Interest Expense
-3.10 -2.03 -76.30 -136.32 -150.40 -472.22 -0.50 -25.05 -20.93 -26.13 26.22
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -0.61% -0.74% -0.58% 0.00% -0.61% -0.30% -0.21% -0.35%

Financials Breakdown Chart

Key Financial Trends

KindlyMD’s latest supplied statements are labeled Nakamoto Inc. (NASDAQ: NAKA), while earlier periods identify the company as Kindly MD (KDLY). The figures show a sharp change in reported results during 2026, so comparisons may reflect changes in the business or reporting as well as underlying performance.

In Q3 2026, the company reported $85.5 million in net income, compared with losses of $133.0 million in Q2 and $238.8 million in Q1. However, Q3 revenue was negative $1.9 million, and the reported profit was driven largely by a $100.3 million credit in other operating expenses/(income). The quarter’s earnings therefore do not, on their own, demonstrate stronger recurring operations.

  • Current assets rose to $29.0 million from $27.5 million in Q2, while current liabilities fell to $127.4 million from $179.5 million. The current ratio improved to about 0.23 from 0.15, though current assets still do not cover current liabilities.
  • Total debt was approximately flat quarter over quarter at $164.9 million, versus $164.7 million in Q2. Its reported mix shifted from predominantly short-term debt to roughly $104.9 million short-term and $60.0 million long-term debt.
  • Q3 net income of $85.5 million was a sharp reversal from the prior two quarters’ losses, but the unusual operating credit and negative reported revenue make the result difficult to treat as a measure of ongoing profitability.
  • Cash and equivalents edged up to $19.4 million from $19.1 million in Q2. Total assets also increased to $517.2 million from $422.5 million, with much of the change in noncurrent assets, including other noncurrent operating assets.
  • Revenue was highly volatile in the available periods: $2.7 million in Q1 2026, $35.9 million in Q2, and negative $1.9 million in Q3. Earlier reported quarters generally showed much lower revenue, making the recent figures difficult to compare without more detail on business changes.
  • Operating cash flow remained negative at $10.3 million in Q3, following outflows of $3.3 million in Q2 and $23.3 million in Q1. Q3’s accounting profit did not translate into cash generated from operations.
  • Liquidity remains a concern: Q3 current liabilities exceeded current assets by about $98.4 million, and cash of $19.4 million was well below the $127.4 million of current liabilities.
  • The company recorded substantial net losses in Q1 and Q2 2026, while Q3’s unusual income credit and negative revenue leave the sustainability of its reported profit uncertain.
11/19/26 12:38 AM ETAI Generated. May Contain Errors.

Kindly MD Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Kindly MD's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Kindly MD's net income appears to be on a downward trend, with a most recent value of -$52.23 million in 2025, falling from -$1.62 million in 2023. The previous period was -$3.62 million in 2024.

Kindly MD's total operating income in 2025 was -$197.14 million, based on the following breakdown:
  • Total Gross Profit: $1.82 million
  • Total Operating Expenses: $198.96 million

Over the last 2 years, Kindly MD's total revenue changed from $3.77 million in 2023 to $1.82 million in 2025, a change of -51.7%.

In the past 10 quarters, Kindly MD's cash and equivalents has ranged from $287.38 thousand in Q1 2024 to $35.30 million in Q1 2026, and is currently $19.42 million as of their latest financial filing in Q3 2026.

Kindly MD had total debt of $209.56 million at the end of 2025, a 150,361.3% increase from 2024, and a 55,428.5% increase since 2023.

Over the last 2 years, Kindly MD's book value per share changed from -0.02 in 2023 to 1.17 in 2025.



Financial statements for NASDAQ:NAKAW last updated on 11/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners